US Patent 11958894 Anti-VEGF protein compositions and methods for producing the same

Is a

Patent

Patent attributes

Patent Applicant

Regeneron Pharmaceuticals

Current Assignee

Regeneron Pharmaceuticals

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

119588940

Patent Inventor Names

Shawn M. Lawrence0

Ning Li0

Shunhai Wang0

Amy S. Johnson0

Amardeep Singh Bhupender Bhalla0

Jaimie Grapel0

Hunter Chen0

Meghan Casey0

Date of Patent

April 16, 2024

Patent Application Number

182137790

Date Filed

June 23, 2023

Patent Citations

‌

US Patent 9670519 Methods for reducing accumulation of lactate during culturing and method for producing polypeptide

‌

US Patent 10017732 Cell culture compositions with antioxidants and methods for polypeptide production

‌

US Patent 10676710 Cell culture compositions with antioxidants and methods for polypeptide production

‌

US Patent 10927342 Taurine supplemented cell culture medium and methods of use

‌

US Patent 11053280 Anti-VEGF protein compositions and methods for producing the same

‌

US Patent 11174283 Anti-VEGF protein compositions and methods for producing the same

‌

US Patent 11186625 Anti-VEGF protein compositions and methods for producing the same

‌

US Patent 11299532 Anti-VEGF protein compositions and methods for producing the same

...

Patent Primary Examiner

‌

Sudhakar Katakam

Patent abstract

The present disclosure pertains to compositions comprising anti-VEGF proteins and methods for producing such compositions.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

US Patent 11958894 Anti-VEGF protein compositions and methods for producing the same

Contents

Patent attributes

Timeline

Further Resources

References

Find more entities like US Patent 11958894 Anti-VEGF protein compositions and methods for producing the same